Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)
There are no set rules for how long to wait between these medications
Add premium coaching (optional)
Data indicates additive effects, with weight loss comparable to or potentially exceeding that of tirzepatide
Your doctor may recommend adjusting your dose, pausing titration, or trying an over-the-counter antidiarrheal medication like loperamide
A Promising Weight Loss Treatment We accept hundreds of insurance plans And many more